JW Shinyak KRX:067290KOSDAQ

JW신약 · Korean news coverage and regulatory filings, organized.

Articles, 24h1
Articles, 7 days2
DART filings, 7 days0
Articles tracked2since Sep 11

In Q2 2026, JW Shinyak reported revenue of ₩21.5bn, up 9.4% year on year, and operating profit of ₩3.6bn. JW Shinyak (JW신약) appeared in 2 Korean news articles and 0 DART filings over the past seven days. Coverage peaked on Sep 11 with 1 article.

JW Shinyak quarterly results separate, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩21.5bn+9.4%₩3.6bn₩3.6bn
Q1 2026₩21.4bn+8.8%₩2.9bn₩2.7bn
Q4 2025 derived₩21.1bn+31.2%₩1.4bn₩2.0bn
Q3 2025₩20.6bn-34.7%₩2.7bn₩2.0bn
Q2 2025₩19.7bn-8.9%₩2.7bn₩3.1bn
Q1 2025₩19.7bn-17.4%₩667m₩8.6bn
Q4 2024 derived₩16.1bn-34.3%−₩2.9bn−₩3.5bn
Q3 2024₩31.5bn+13.5%₩8.1bn₩5.9bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases.

JW Shinyak top stories 2 weeks, by number of outlets

  1. 1
    JW신약 주가, 9월 15일 장중 3,660원 7.65% 상승
    1 outlets · 1 articlesFirst report Sep 15 11:14 중앙이코노미뉴스
  2. 2
    JW신약 주가, 9월 11일 장중 3,560원 1.66% 하락
    1 outlets · 1 articlesFirst report Sep 11 14:05 중앙이코노미뉴스

Latest JW Shinyak news Korean headlines